IRCT20091201002804N12
Recruiting
Phase 3
The effect of surfactant on clinical outcome of patients with COVID-19 under mechanical ventilation
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Mortality of Patients from COVID-19.
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •if the patient is intubated and under mechanical ventilation with SpO2\<85%
- •If the patient has confirmed COVID\-19
Exclusion Criteria
- •Coexisting underlying pulmonary disease except for COVID\-19
- •Underlying congenital hear disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 3
Effect different doses of Surfactant (CUROSURF)Respiratory distress syndrome of newborn (RDS).Respiratory distress syndrome of newbornP22.0IRCT20210102049921N1Birjand University of Medical Sciences50
Completed
Not Applicable
The effect of the use of surfactant administration during NCPAP treatment on complications of RDSRespiratory Distress Syndrome in the newborn.Respiratory Distress syndromeIRCT201205213512N2Mazandaran University of Medical Siences60
Recruiting
Phase 3
Comparison of efficacy and safety of surfactant administration by MIST and INSURE techniques in Respiratory Distress Syndrome.Surfactant therapyRespiratory distress syndromeSurfactantMISTInSurERespiratory distress syndromePretermTCTR20210627001Self106
Active, not recruiting
Phase 1
The efficacy and mechanism of surfactant therapy for critically ill infants with bronchiolitis: the Bronchiolitis Endotracheal Surfactant Study (BESS)Critical Illness due to Bronchiolitis of infancy requiring conventional invasive Mechanical Ventilation (MV) Diagnosis of bronchiolitis per clinical criteria defined in national guidance NICE-NG9.MedDRA version: 20.1 Level: PT Classification code 10038718 Term: Respiratory syncytial virus bronchiolitis System Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.1 Level: PT Classification code 10065188 Term: Lower respiratory tract infection viral System Organ Class: 10021881 - Infections and infestationsTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]EUCTR2018-001169-18-GBniversity Of Liverpool284
Completed
Phase 2
Comparing the efficacy of surfactant administration by laryngeal mask airway (LMA) and endotracheal intubatioRespiratory Distress Syndrome.Respiratory distress syndromeIRCT201411183915N12Research Vice Chancellor for Tabriz University of Medical Sciences70